Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2025-12-24 @ 5:38 PM
NCT ID:
NCT06243068
Eligibility Criteria:
Study Population 1: Person with CKD, cared for at participating clinic
Inclusion Criteria:
* Age 65 years or older
* Most recent eGFR \<30 at time of screening AND meets practice site criteria for KDE referral
* Treatment naïve (no dialysis or kidney transplant prior to enrollment)
Exclusion Criteria:
* The patient is a transplant candidate.
* The current decrease in eGFR is thought to be due to an acute event.
* Education and initiation of shared decision-making process are not yet indicated for the patient, (per practice protocol and/or provider's judgment).
Exclusion Criteria for primary analysis:
\- Insufficient decision making capacity (Outcomes for this group will be described separately.)
Exclusion Criteria for surveys and interviews:
* Insufficient decision making capacity
* Non-English and non-Spanish speaking
* Treating nephrologist/APP opts patient out (for example, if contraindicated for patient's health)
Study Population 2: Family member or caregiver of patient in Study Population 1
Inclusion Criteria:
* Family member or caregiver of Population 1 patient who has chosen alternative treatment plan
* 18+ years old
* English or Spanish speaking
* Cognitively able to participate in surveys/interviews
Study Population 3: Administrator, clinical provider, or staff at participating chronic kidney disease clinic
Inclusion Criteria:
\- Currently practicing or employed at participating clinic
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT06243068
Study Brief:
Protocol Section:
NCT06243068